Literature DB >> 3802039

Diagnosis of pulmonary Kaposi's sarcoma with fiberoptic bronchoscopy and endobronchial biopsy. A report of five cases.

P G Hamm, M A Judson, C P Aranda.   

Abstract

Fiberoptic bronchoscopy is a major tool in the diagnostic evaluation of pulmonary disease in patients with the Acquired Immune Deficiency Syndrome. Multiple opportunistic infections and Kaposi's sarcoma affect the lung in this disorder. In contrast to opportunistic infections, Kaposi's sarcoma is rarely reported to be diagnosed by means of bronchoscopy. This report describes five of seven patients in whom endobronchial lesions consistent with submucosal involvement by the tumor were seen, and Kaposi's sarcoma was diagnosed without complication. Kaposi's sarcoma must be considered in the differential diagnosis of pulmonary disease in patients with a proven extrapulmonary tumor focus, and fiberoptic bronchoscopy is the initial diagnostic procedure of choice. Endobronchial Kaposi's sarcoma may be a marker for parenchymal involvement by the tumor. Diagnosis of endobronchial Kaposi's sarcoma can be an important factor in decisions regarding therapy.

Entities:  

Mesh:

Year:  1987        PMID: 3802039     DOI: 10.1002/1097-0142(19870215)59:4<807::aid-cncr2820590425>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

Review 1.  AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

Review 2.  Lung Malignancies in HIV Infection.

Authors:  Keith Sigel; Robert Pitts; Kristina Crothers
Journal:  Semin Respir Crit Care Med       Date:  2016-03-14       Impact factor: 3.119

3.  Bronchopulmonary Kaposi's sarcoma in patients with AIDS.

Authors:  D M Mitchell; M McCarty; J Fleming; F M Moss
Journal:  Thorax       Date:  1992-09       Impact factor: 9.139

Review 4.  Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes.

Authors:  Gail E Reid; Joseph P Lynch; Samuel Weigt; David Sayah; John A Belperio; Shellee A Grim; Nina M Clark
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

Review 5.  Noninfectious pulmonary complications of human immunodeficiency virus infection.

Authors:  Bashar Staitieh; David M Guidot
Journal:  Am J Med Sci       Date:  2014-12       Impact factor: 2.378

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.